2-173191110-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000375213.8(MAP3K20):c.515G>A(p.Trp172Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000375213.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K20 | NM_016653.3 | c.515G>A | p.Trp172Ter | stop_gained | 7/20 | ENST00000375213.8 | NP_057737.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K20 | ENST00000375213.8 | c.515G>A | p.Trp172Ter | stop_gained | 7/20 | 1 | NM_016653.3 | ENSP00000364361 | P1 | |
MAP3K20-AS1 | ENST00000422703.5 | n.338+1831C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461754Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727174
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Myopathy, centronuclear, 6, with fiber-type disproportion Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 28, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 19, 2022 | ClinVar contains an entry for this variant (Variation ID: 446159). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with congenital myopathy (PMID: 27816943). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp172*) in the MAP3K20 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MAP3K20 are known to be pathogenic (PMID: 27816943). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at